India Approves First Dengue Vaccine QDENGA

India has approved its first dengue vaccine, QDENGA, after receiving clearance from the Drugs Controller General of India (DCGI). This move is significant as dengue is a major public health concern in the country.

Dengue is a mosquito-borne viral disease that is reported in more than 125 countries worldwide. In India, the disease is a significant burden, accounting for nearly one-third of the global dengue cases. The rapid urbanisation, climate change, and widespread mosquito breeding in the country have increased the risk of infection.

The QDENGA vaccine is administered in two injections of 0.5 ml each, given under the skin three months apart. This vaccine has the potential to provide protection against dengue, which is a major cause of illness and death in the country.

The approval of QDENGA is a major milestone in the fight against dengue in India. The vaccine has undergone rigorous testing and has been found to be safe and effective. The DCGI clearance is a significant step towards making the vaccine available to the public.

Dengue is a major public health concern in India, with the country accounting for a significant proportion of global cases. The disease is spread by the Aedes mosquito, which is found in many parts of the country. The symptoms of dengue include fever, headache, and joint pain, and in severe cases, it can cause bleeding and low blood platelets.

The approval of QDENGA is expected to have a significant impact on public health in India. The vaccine has the potential to reduce the burden of dengue in the country and provide protection to millions of people who are at risk of infection.

In recent years, India has taken several steps to control the spread of dengue, including launching awareness campaigns and implementing measures to prevent mosquito breeding. The approval of QDENGA is a major addition to these efforts and is expected to play a significant role in reducing the incidence of dengue in the country.

The QDENGA vaccine is a major breakthrough in the fight against dengue, and its approval is a significant step towards providing protection to people against this disease. With the vaccine expected to be made available to the public soon, it is hoped that it will have a major impact on public health in India and help to reduce the burden of dengue in the country.

In conclusion, the approval of QDENGA is a significant development in the fight against dengue in India. The vaccine has the potential to provide protection to millions of people and reduce the burden of dengue in the country. As India continues to grapple with the challenges of dengue, the approval of QDENGA is a major step forward and is expected to have a significant impact on public health in the country.